Roivant
Roivant is rapidly developing innovative medicines through a novel form of industrial organization in R&D.
Leadership
Matthew Gline
Sector
Health Tech
Region
Americas
Our investment in Roivant has now been fully divested.
This site uses cookies to improve your experience.
We use necessary cookies to make our site work. We would also like to set optional analytics cookies to help us improve our site by anonymously collecting and reporting information on how you use it. For more information on how these cookies work, please see our Cookie Policy.
10
Goodbye, for now.